Edwards Lifesciences Corp (NYSE:EW)
| 232.64 Delayed Data As of 6:30pm ET |  +1.94 / +0.84%Today’s Change | 139.64 Today|||52-Week Range 247.64 | +51.88% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 230.70 |
| Today’s open | 229.71 |
| Day’s range | 229.70 - 233.10 |
| Volume | 1,045,363 |
| Average volume (3 months) | 1,123,915 |
| Market cap | $49.8B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +24.55% |
| Earnings growth (this year) | +19.14% |
| Earnings growth (next 5 years) | +13.47% |
| Revenue growth (last year) | +8.37% |
| P/E ratio | 63.7 |
| Price/Sales | 8.79 |
| Price/Book | 15.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | -1.32 | -0.23% |
| SYKStryker Corp | +3.16 | +1.58% |
| SNNSmith & Nephew PLC | +1.36 | +3.03% |
| STESteris plc | -1.73 | -1.13% |
Data as of 6:30pm ET, 12/13/2019
Financials
| Next reporting date | February 11, 2020 |
| EPS forecast (this quarter) | $1.48 |
| Annual revenue (last year) | $3.7B |
| Annual profit (last year) | $722.2M |
| Net profit margin | 19.40% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
